Page last updated: 2024-12-04

2,3-dihydroxybiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3-dihydroxybiphenyl: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

biphenyl-2,3-diol : A member of the class of hydroxybiphenyls that is 1,1'-biphenyl substituted by hydroxy groups at positions 2 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID254
CHEBI ID16205
SCHEMBL ID94298
MeSH IDM0424703

Synonyms (27)

Synonym
CHEBI:16205
(1,1'-biphenyl)-2,3-diol
[1,1'-biphenyl]-2,3-diol
2,3-dihydroxybiphenyl
2,3-biphenyldiol
C02526
biphenyl-2,3-diol
1133-63-7
3-phenylcatechol
3-phenylpyrocatechol
1KMY
DB02923
3-phenylbenzene-1,2-diol
xqt8n5388z ,
unii-xqt8n5388z
SCHEMBL94298
AKOS022642138
YKOQAAJBYBTSBS-UHFFFAOYSA-N
DTXSID60150353
J-002953
2,3-dihydroxy-biphenyl
2,3-dihydroxy-biphenyl, for gc derivatization, >=98.0%
Q27093908
CS-0353770
pyrocatechol, 3-phenyl-
1,2-benzenediol, 3-phenyl-
EN300-1599481
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
hydroxybiphenylsAny member of the class of biphenyls that has one or more hydroxy groups attached to the benzenoid ring system.
catecholsAny compound containing an o-diphenol component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
2-hydroxybiphenyl degradation011
biphenyl degradation212
2-hydroxybiphenyl degradation317

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2,3-dihydroxybiphenyl 1,2-dioxygenaseParaburkholderia xenovorans LB400Kd8.00008.00008.00008.0000AID977611
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB1998The Journal of biological chemistry, Dec-25, Volume: 273, Issue:52
Molecular basis for the stabilization and inhibition of 2, 3-dihydroxybiphenyl 1,2-dioxygenase by t-butanol.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's10 (55.56)29.6817
2010's7 (38.89)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.64 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]